First Trust Direct Indexing’s BeOne Medicines Ltd ONC Stock Holding History

First Trust Direct Indexing’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,808	Closed	-$506K	–	858
2023 Q4	$506K	Sell	2,808 -433	-13%	-$78.3K	0.05%	442
2023 Q3	$583K	Sell	3,241 -330	-9%	-$65.3K	0.07%	348
2023 Q2	$637K	Sell	3,571 -620	-15%	-$143K	0.07%	336
2023 Q1	$903K	Buy	4,191 +270	+7%	+$64.8K	0.11%	240
2022 Q4	$862K	Buy	3,921 +2,142	+120%	+$393K	0.11%	241
2022 Q3	$240K	Sell	1,779 -281	-14%	-$48.3K	0.04%	526
2022 Q2	$333K	Buy	+2,060	New	+$322K	0.05%	443

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

First Trust Direct Indexing's ONC Position: Q1 2024 in Review

First Trust Direct Indexing sold out of BeOne Medicines Ltd (ONC) in Q1 2024, closing a stake of 2,808 shares — an estimated $506K sold.

First Trust Direct Indexing first reported a position in ONC in Q2 2022 and held it in 7 quarters. The position peaked at $903K in Q1 2023. 205 funds tracked by Wall St. Rank hold ONC as of Q1 2024.

First Trust Direct Indexing reported no remaining BeOne Medicines Ltd position as of Q1 2024 after selling out during the quarter.
First Trust Direct Indexing sold 2,808 BeOne Medicines Ltd shares in Q1 2024, an estimated $506K.
First Trust Direct Indexing first reported a position in BeOne Medicines Ltd in Q2 2022 and held it in 7 quarters.
First Trust Direct Indexing's BeOne Medicines Ltd position peaked at $903K in Q1 2023.
205 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2024.

Based on First Trust Direct Indexing's 13F filing for Q1 2024, filed 19 Apr 2024.